ILAE-North America
The current ILAE-North America region was constituted in 2006, comprising English speaking North American Chapters of Canada, the United States of America, and the English speaking Caribbean (represented by Jamaica). The Mexican chapter, although geographically in North America, is a member of the Latin American Regional Commission.
Our goals and aims are aligned with the ILAE’s emphasis on current and emerging knowledge on epilepsy prevention, diagnosis, treatment, research, and optimal comprehensive epilepsy care.
NEW! Global Health in Epilepsy Project Database
The Global Health Task Force has just launched an initiative to identify and connect international projects aimed at reducing the global epilepsy treatment gap, and it is now accepting ongoing, completed, and upcoming projects.
The goals are to increase collaboration, amplify impact, reduce redundancy, engage possible funders, and identify service opportunities.
Latest News
Clinical Research
Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study
Outcomes of children at 2 years of age did not differ between children of WWE taking ASMs and children of healthy women.
8 June, 2021
World News
In memoriam: Alan Richens
We are saddened to report the death of Alan Richens, recognized internationally for his research and a major driving force behind the impressive developments in the clinical pharmacology of epilepsy which took place in the 70s and the 80s.
7 June, 2021
About ILAE
Final results for election of ILAE regional officers
The Elections Committee is pleased to announce that the ILAE regional elections have been completed. The elected officers of the six Regional Boards for the 2021-2025 term are as follows. The Elections Committee congratulates all the elected officers and wishes them a successful service for the next four years.
25 May, 2021
Clinical Research
Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures
In this comparative effectiveness study, no difference was found in functional neurodevelopment or epilepsy at age 24 months among children whose ASM was discontinued vs maintained at hospital discharge after resolution of acute symptomatic neonatal seizures. These results support discontinuation of ASM prior to hospital discharge for most infants with acute symptomatic neonatal seizures.
24 May, 2021
About ILAE
Comments needed on proposed Classification and Definition of Epilepsy Syndromes
The ILAE seeks your comments on four papers prepared by the Task Force on Nosology and Definitions that provide the definitions for the many epilepsy syndromes at various ages. These definitions will become the League’s formal positions on these syndromes once edited and approved. Deadline is 15 July.
19 May, 2021
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community